Ropivacaine Other names: Ropivacaine hydrochloride

Chemical formula: C₁₇H₂₆N₂O Molecular mass: 274.401 g/mol PubChem compound: 175805

Therapeutic indications

Ropivacaine is indicated for:

Lumbar epidural anaesthesia for acute pain management

Population group: only adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Lumbar epidural block and additionally at least one of

Acute pain
Acute pain control management

For this indication, competent medicine agencies globally authorize below treatments (click for details):

2-200 mg depending on the block

Thoracic epidural anaesthesia for postoperative pain management

Population group: only adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Local anaesthetic thoracic epidural block and additionally at least one of

Acute pain
Acute pain control management

For this indication, competent medicine agencies globally authorize below treatments (click for details):

12-28 mg/h

Local anaesthesia for acute pain management

Population group: only adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Local anaesthesia and additionally at least one of

Acute pain
Acute pain control management

For this indication, competent medicine agencies globally authorize below treatments (click for details):

2-200 mg

Peripheral nerve block for acute pain management

Population group: only adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Peripheral block anesthesia and additionally at least one of

Acute pain
Acute pain control management

For this indication, competent medicine agencies globally authorize below treatments (click for details):

10-20 mg/h

Peripheral nerve block for acute pain management

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

During surgery and postoperatively.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

1-3 mg/kg single injection or 0,2-0,6 mg/kg/h continuous infusion up to 72h

Caudal epidural block for acute pain management

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

During surgery and postoperatively.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

2 mg/kg once

Contraindications

Ropivacaine is contraindicated in the following cases:

Hypovolaemia

Hypovolemia

Strong CYP1A2 inhibitors

Strong CYP1A2 inhibitors

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈